# Immune Response To Intranasal Influenza Vaccination

> **NCT01866540** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Bergen** · enrollment: 300 (estimated)

## Conditions studied

- Tonsillitis, Hypertrophy

## Interventions

- **DRUG:** FLUENZ

## Key facts

- **NCT ID:** NCT01866540
- **Lead sponsor:** University of Bergen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-10-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01866540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01866540, "Immune Response To Intranasal Influenza Vaccination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01866540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*